ETON PHARMACEUTICALS INC (ETON) Stock Balance Sheet
NASDAQ:ETON - Nasdaq - US29772L1089 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 20.26M | 21.39M | 16.31M | 14.41M | 21.30M | |||
| Receivables | 5.59M | 3.41M | 1.85M | 5.47M | 50.00K | |||
| Inventories | 1.94M | 911.00K | 560.00K | 550.00K | 1.24M | |||
| Other Current Assets | 1.96M | 1.13M | 1.29M | 3.18M | 2.12M | |||
| Total Current Assets | 29.75M | 26.84M | 20.00M | 23.60M | 24.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 226.00K | 150.00K | 260.00K | 220.00K | 1.00M | |||
| Intangibles | 5.85M | 4.74M | 4.75M | 3.62M | 580.00K | |||
| Other Non-Current Assets | 12.00K | 12.00K | 10.00K | 20.00K | 40.00K | |||
| Total Non-Current Assets | 6.09M | 4.90M | 5.03M | 3.87M | 1.62M | |||
| TOTAL ASSETS | 35.84M | 31.74M | 25.03M | 27.47M | 26.32M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.13M | 5.38M | 1.03M | 1.42M | 280.00K | |||
| Accrued Expenses | 12.93M | 9.01M | 3.74M | 1.37M | 1.17M | |||
| Accounts Payable | 2.68M | 1.85M | 1.69M | 1.77M | 2.34M | |||
| Total Current Liabilities | 19.73M | 16.24M | 6.46M | 4.56M | 3.79M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 5.38M | 5.26M | 6.76M | |||
| Other Non-Current Liabilities | 126.00K | 22.00K | 110.00K | 20.00K | 100.00K | |||
| Total Non-Current Liabilities | 126.00K | 22.00K | 5.49M | 5.28M | 6.87M | |||
| TOTAL LIABILITIES | 19.86M | 16.26M | 11.95M | 9.84M | 10.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -107.30M | -104.07M | -103.13M | -94.11M | -92.16M | |||
| Additional Paid In Capital | 123.25M | 119.52M | 116.19M | 111.72M | 107.80M | |||
| Common Shares | 26.00K | 26.00K | 30.00K | 30.00K | 20.00K | |||
| Shares Outstanding | 25.84M | 25.69M | 25.35M | 24.63M | 24.31M | |||
| Tangible Book Value per Share | 0.39 | 0.42 | 0.33 | 0.57 | 0.62 | |||
| Total Shareholders' Equity | 15.98M | 15.48M | 13.08M | 17.63M | 15.66M | |||
| TOTAL LIABILITIES AND EQUITY | 35.84M | 31.74M | 25.03M | 27.47M | 26.32M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.41 | 0.30 | 0.43 | |||
| Current Ratio | 1.51 | 1.65 | 3.10 | 5.18 | 6.52 | |||
| Return On Assets (ROA) | -15.29% | -2.95% | -36.04% | -7.14% | -106.27% | |||
| Return On Equity (ROE) | -34.30% | -6.05% | -68.96% | -11.12% | -178.61% | |||
All data in USD , ROIC based on taxRate of 0.21